Generic name |
dipyridamole-acetylsalicylic acid |
---|---|
Strength |
dipyridamole + acetylsalicylic acid combination 200/25 mg |
Form |
tablet |
Special Authority criteria |
Approval period |
---|---|
For secondary prevention of cerebrovascular occlusion and embolization in patients who have experienced recurrent TIA or stroke while receiving ASA alone. |
Indefinite |